Article Text

Download PDFPDF

Using a period incidence survey to compare antibiotic use in children between a university hospital and a district hospital in a country with low antimicrobial resistance: a prospective observational study
  1. Christian Magnus Thaulow1,
  2. Hege Salvesen Blix2,3,
  3. Beate Horsberg Eriksen1,
  4. Ingvild Ask4,
  5. Tor Åge Myklebust5,
  6. Dag Berild6
  1. 1Department of Pediatrics, Møre and Romsdal Hospital Trust, Ålesund, Norway
  2. 2Faculty of Medicine, Department of Pharmacology, University of Oslo, Oslo, Norway
  3. 3Department of Drug Statistics, Norwegian Institute of Public Health, Oslo, Norway
  4. 4Pediatric Department, Oslo University Hospital, Oslo, Norway
  5. 5Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway
  6. 6Department of Infectious Diseases, University of Oslo, Oslo, Norway
  1. Correspondence to Dr Christian Magnus Thaulow; cmt85{at}hotmail.com

Abstract

Objectives To describe and compare antibiotic use in relation to indications, doses, adherence rate to guidelines and rates of broad-spectrum antibiotics (BSA) in two different paediatric departments with different academic cultures, and identify areas with room for improvement.

Design Prospective observational survey of antibiotic use.

Setting Paediatric departments in a university hospital (UH) and a district hospital (DH) in Norway, 2017. The registration period was 1 year at the DH and 4 months at the UH.

Participants 201 children at the DH (mean age 3.8: SD 5.1) and 137 children at the UH (mean age 2.0: SD 5.9) were treated with systemic antibiotics by a paediatrician in the study period and included in the study.

Outcome measures Main outcome variables were prescriptions of antibiotics, treatments with antibiotics, rates of BSA, median doses and adherence rate to national guidelines.

Results In total, 744 prescriptions of antibiotics were given at the UH and 638 at the DH. Total adherence rate to guidelines was 75% at the UH and 69% at the DH (p=0.244). The rate of treatments involving BSA did not differ significantly between the hospitals (p=0.263). Use of BSA was related to treatment of central nervous system (CNS) infections, patients with underlying medical conditions or targeted microbiological treatment in 92% and 86% of the treatments, at the UH and DH, respectively (p=0.217). A larger proportion of the children at the DH were treated for respiratory tract infections (p<0.01) compared with the UH. Children at the UH were treated with higher doses of ampicillin and cefotaxime (p<0.05) compared with the DH.

Conclusion Our results indicate that Norwegian paediatricians have a common understanding of main aspects in rational antibiotic use independently of working in a UH or DH. Variations in treatment of respiratory tract infections and in doses of antibiotics should be further studied.

  • epidemiology
  • infection control

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CMT, DB, HSB and BHE were involved in the development of the protocol. CMT developed the registration form and was responsible for the data collection at Ålesund Hospital. IA was responsible for the data collection at Oslo University Hospital, Ullevål. CMT and TÅM did the analyses. CMT wrote the first draft. All the authors contributed to the interpretation of the data and revisions of the manuscript and approved the final version of the manuscript.

  • Funding This work was supported by a grant from Møre and Romsdal Hospital Trust (2018/1527-3).

  • Competing interests None declared.

  • Ethics approval The study was approved by the Regional Committee for Medical and Health Research Ethics (2017/30/REK Midt) and by the Local Data Protection Officials at the two hospitals.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Datafiles with deidentified patient data from the registration in both hospitals are kept by the first author and are available from him upon request. The project protocol is attached in this submission.

  • Correction notice This article has been corrected since it first published. Supplementary file 2 and Table 3 have been updated.

  • Patient consent for publication Obtained.